Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Company Reports
BioPartners
BioPartners
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
No data
Company Revenue
No data
Revenue by Drug
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
Ribavirin biopartners
Ribavirin
2010-04-06
Chronic hepatitis c
,
Virus diseases
,
Respiratory syncytial virus infections
,
West nile fever
,
Human adenovirus infections
,
Renal cell carcinoma
,
Colorectal neoplasms
,
Brain neoplasms
,
Hepatocellular carcinoma
,
Essential thrombocythemia
,
Multiple myeloma
,
Sezary syndrome
,
Skin neoplasms
,
Melanoma
,
Chronic hepatitis b
,
Hemangioma
,
Thrombocytopenia
,
Macular degeneration
,
Mycosis fungoides
,
Hairy cell leukemia
,
Hepatitis d
,
Hypereosinophilic syndrome
,
Kaposi sarcoma
,
Warts
,
Skin ulcer
,
Cryoglobulinemia
,
Ileal neoplasms
Somatropin biopartners
Somatropin
2013-08-05
Heart failure
,
Prader-willi syndrome
,
Cachexia
,
Pituitary dwarfism
,
Turner syndrome
,
Noonan syndrome
,
Dwarfism
,
Growth
Valtropin
Somatropin
2006-04-24
Heart failure
,
Prader-willi syndrome
,
Cachexia
,
Pituitary dwarfism
,
Turner syndrome
,
Noonan syndrome
,
Dwarfism
,
Growth
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Somatropin
laron syndrome
,
endocrine system diseases
,
pituitary dwarfism
,
pituitary diseases
Somatropin pegol
laron syndrome
,
endocrine system diseases
,
pituitary dwarfism
,
pituitary diseases
Interferon beta
multiple sclerosis
,
relapsing-remitting multiple sclerosis
Albumin
multiple sclerosis
,
relapsing-remitting multiple sclerosis
Etrolizumab
multiple sclerosis
,
relapsing-remitting multiple sclerosis
Sodium chloride
multiple sclerosis
,
relapsing-remitting multiple sclerosis
Manitol
multiple sclerosis
,
relapsing-remitting multiple sclerosis
Bolus
multiple sclerosis
,
relapsing-remitting multiple sclerosis
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use